Logo image of AAQ1.DE

AAP IMPLANTATE (AAQ1.DE) Stock Fundamental Analysis

FRA:AAQ1 - Deutsche Boerse Ag - DE000A3H2101 - Common Stock - Currency: EUR

1.46  +0.01 (+0.69%)

Fundamental Rating

2

Taking everything into account, AAQ1 scores 2 out of 10 in our fundamental rating. AAQ1 was compared to 53 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of AAQ1 have multiple concerns. AAQ1 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AAQ1 had negative earnings in the past year.
AAQ1 had a negative operating cash flow in the past year.
In the past 5 years AAQ1 always reported negative net income.
In the past 5 years AAQ1 always reported negative operating cash flow.
AAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFAAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.54%, AAQ1 is doing worse than 69.81% of the companies in the same industry.
AAQ1's Return On Equity of -41.50% is on the low side compared to the rest of the industry. AAQ1 is outperformed by 67.92% of its industry peers.
Industry RankSector Rank
ROA -26.54%
ROE -41.5%
ROIC N/A
ROA(3y)-16.66%
ROA(5y)-33.86%
ROE(3y)-28.99%
ROE(5y)-55.37%
ROIC(3y)N/A
ROIC(5y)N/A
AAQ1.DE Yearly ROA, ROE, ROICAAQ1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80 -100

1.3 Margins

With an excellent Gross Margin value of 84.83%, AAQ1 belongs to the best of the industry, outperforming 90.57% of the companies in the same industry.
In the last couple of years the Gross Margin of AAQ1 has declined.
AAQ1 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.19%
GM growth 5Y-2.35%
AAQ1.DE Yearly Profit, Operating, Gross MarginsAAQ1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

More info and screens

3

2. Health

2.1 Basic Checks

AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AAQ1 has more shares outstanding
AAQ1 has more shares outstanding than it did 5 years ago.
AAQ1 has a worse debt/assets ratio than last year.
AAQ1.DE Yearly Shares OutstandingAAQ1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
AAQ1.DE Yearly Total Debt VS Total AssetsAAQ1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

AAQ1 has an Altman-Z score of -0.11. This is a bad value and indicates that AAQ1 is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AAQ1 (-0.11) is worse than 66.04% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that AAQ1 is not too dependend on debt financing.
AAQ1's Debt to Equity ratio of 0.17 is fine compared to the rest of the industry. AAQ1 outperforms 77.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.11
ROIC/WACCN/A
WACC6.79%
AAQ1.DE Yearly LT Debt VS Equity VS FCFAAQ1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

AAQ1 has a Current Ratio of 2.12. This indicates that AAQ1 is financially healthy and has no problem in meeting its short term obligations.
AAQ1 has a better Current ratio (2.12) than 60.38% of its industry peers.
AAQ1 has a Quick Ratio of 1.03. This is a normal value and indicates that AAQ1 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.03, AAQ1 is in line with its industry, outperforming 52.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.03
AAQ1.DE Yearly Current Assets VS Current LiabilitesAAQ1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AAQ1 have decreased strongly by -43.53% in the last year.
The Revenue has decreased by -0.33% in the past year.
AAQ1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.26% yearly.
EPS 1Y (TTM)-43.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.72%
Revenue 1Y (TTM)-0.33%
Revenue growth 3Y7.17%
Revenue growth 5Y1.26%
Sales Q2Q%121.74%

3.2 Future

Based on estimates for the next years, AAQ1 will show a very strong growth in Earnings Per Share. The EPS will grow by 35.68% on average per year.
The Revenue is expected to grow by 12.81% on average over the next years. This is quite good.
EPS Next Y54.55%
EPS Next 2Y35.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.04%
Revenue Next 2Y15.21%
Revenue Next 3Y19.72%
Revenue Next 5Y12.81%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AAQ1.DE Yearly Revenue VS EstimatesAAQ1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10M 20M 30M
AAQ1.DE Yearly EPS VS EstimatesAAQ1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AAQ1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AAQ1. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAQ1.DE Price Earnings VS Forward Price EarningsAAQ1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAQ1.DE Per share dataAAQ1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

AAQ1's earnings are expected to grow with 35.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.68%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AAQ1!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AAP IMPLANTATE

FRA:AAQ1 (4/23/2025, 7:00:00 PM)

1.46

+0.01 (+0.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2024-11-14
Earnings (Next)04-30 2025-04-30/amc
Inst Owners17.31%
Inst Owner ChangeN/A
Ins Owners6.61%
Ins Owner ChangeN/A
Market Cap20.31M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.77
P/FCF N/A
P/OCF N/A
P/B 1.64
P/tB 1.95
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.83
BVpS0.89
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.54%
ROE -41.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.83%
FCFM N/A
ROA(3y)-16.66%
ROA(5y)-33.86%
ROE(3y)-28.99%
ROE(5y)-55.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.19%
GM growth 5Y-2.35%
F-Score2
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.26%
Cap/Sales 2.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.03
Altman-Z -0.11
F-Score2
WACC6.79%
ROIC/WACCN/A
Cap/Depr(3y)27.5%
Cap/Depr(5y)21.44%
Cap/Sales(3y)4.02%
Cap/Sales(5y)6.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.72%
EPS Next Y54.55%
EPS Next 2Y35.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.33%
Revenue growth 3Y7.17%
Revenue growth 5Y1.26%
Sales Q2Q%121.74%
Revenue Next Year15.04%
Revenue Next 2Y15.21%
Revenue Next 3Y19.72%
Revenue Next 5Y12.81%
EBIT growth 1Y-48.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.07%
OCF growth 3YN/A
OCF growth 5YN/A